Breaking News, Collaborations & Alliances, Trials & Filings

Trials & Filings in Brief: Dec. 2, 2013

AcelRx, Ampio, Biogen Idec, Exelixis, Idenix, Polaris

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase I Polaris to begin AML trial . . . read more Phase II Exelixis begins CRPC trial . . . read more Idenix begins HCV trial . . . read more Filings Ampio study ruled pivotal for BLA . . . read more Biogen Idec Alprolix PDUFA date delayed . . . read more Zalviso NDA accepted by FDA . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters